These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2143054)

  • 1. [Polycystic ovary syndrome with excess of prolactin].
    Ataniiazova OA; Orlova VG; Smetnik VP; Afonina LI
    Akush Ginekol (Mosk); 1990 Apr; (4):42-4. PubMed ID: 2143054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome.
    Polson DW; Mason HD; Franks S
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):197-203. PubMed ID: 3117444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant cases of polycystic ovarian disease successfully treated with a combination of corticosteroids, clomiphene, and bromocriptine.
    Homburg R; Ashkenazi J; Goldman J
    Int J Fertil; 1988; 33(6):393-7. PubMed ID: 2906913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum gonadotropin levels and ancillary studies in Stein-Leventhal syndrome treated with clomiphene citrate.
    Gambrell RD; Greenblatt RB; Mahesh VB
    Obstet Gynecol; 1971 Dec; 38(6):850-62. PubMed ID: 5125433
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between prolactin and dehydroepiandrosterone sulfate in women with polycystic ovary disease].
    Bruno B; Poccia G; Masci A
    Minerva Endocrinol; 1985; 10(4):223-7. PubMed ID: 2939335
    [No Abstract]   [Full Text] [Related]  

  • 9. Polycystic ovary syndrome.
    Chihal HJ; Baudier MM
    Am Fam Physician; 1985 Apr; 31(4):159-65. PubMed ID: 3157301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia in polycystic ovary syndrome.
    Luciano AA; Chapler FK; Sherman BM
    Fertil Steril; 1984 May; 41(5):719-25. PubMed ID: 6425087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of bromocryptin in polycystic ovary syndrome].
    Fuhrer J; Cheviakoff S; Rubio V
    Rev Chil Obstet Ginecol; 1989; 54(6):364-9; discussion 369-70. PubMed ID: 2485372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
    Wortsman J; Hirschowitz JS
    Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Namavar Jahromi B
    Arch Gynecol Obstet; 2004 Jan; 269(2):125-9. PubMed ID: 14648180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Perić LA
    J Endocrinol Invest; 1987 Aug; 10(4):389-95. PubMed ID: 3119696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome.
    Ginsburg J; Havard CW
    Br Med J; 1976 Sep; 2(6038):737-40. PubMed ID: 788846
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
    Parsanezhad ME; Alborzi S; Jahromi BN
    Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polycystic ovary--classification and treatment by bromocriptine].
    Taketani Y; Ishikawa H; Kinoshita T; Mizuno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1697-701. PubMed ID: 2946787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androstenedione concentrations following dexamethasone suppression: correlation with clomiphene responsiveness in women with polycystic ovary syndrome.
    Polson DW; Reed MJ; Scanlon MJ; Quiney N; Franks S
    Gynecol Endocrinol; 1988 Sep; 2(3):257-64. PubMed ID: 2976245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J; Shen H; Li J; Huang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.